| Financial Year |
March 31 2023 |
| Monetary Funds |
934,490,165.12 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
213,128,930.61 |
| Accounts Receivable |
320,042,527.58 |
| Advances to Suppliers |
4,650,055.56 |
| Other Receivables |
55,870,122.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
347,927,339.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
112,556,997.59 |
| Total Current Assets |
2,581,012,882.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
7,743,087.82 |
| Investment Properties |
27,746,218.71 |
| Fixed Assetes |
1,169,516,542.83 |
| Under-construction Projects |
233,844,985.45 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
290,852,207.13 |
| R&D expenses |
117,703.02 |
| Goodwill |
1,444,353,322.69 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
3,719,852.18 |
| Other Non-Current Assets |
68,090,988.81 |
| Sub-Total of Non-Current Assets |
3,319,965,923.65 |
| Total Assets |
5,900,978,805.98 |
| Short-Term Loans |
272,463,680.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
936,397,240.72 |
| Accounts Payable |
161,329,703.18 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,983,045.14 |
| Taxes Payable |
18,311,668.59 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
94,326,505.68 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,000,000.00 |
| Other Current Liabilities |
34,256,679.33 |
| Sub-Total of Current Liabilities |
1,539,015,923.63 |
| Long-term Loans |
124,950,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
668,345.64 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
126,304,813.94 |
| Total Liabilities |
1,665,320,737.57 |
| Paid-In Capital(Or Share Stock) |
408,552,567.00 |
| Capital Surplus |
2,029,360,766.70 |
| Surplus Reserve |
67,041,649.87 |
| LESS:Treasury Stock |
89,024,000.00 |
| Undistributed Profits |
1,410,491,224.10 |
| Minority Stockholder's Interest |
409,235,860.74 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,826,422,207.67 |
| Owner's Equity（Stockholder's Equity） |
4,235,658,068.41 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,900,978,805.98 |
